Abstract:
The present invention relates to the development of 5'- xanthylic acid (XMP) aminase mutants having enhanced activity using artificial mutagenesis. The 5'-XMP aminase mutants were obtained by performing error-prone PCR to introduce mutations into the native 5'-XMP aminase gene, screening the resulting mutant library for highly active 5'-XMP aminase, performing molecular evolution using the obtained highly active 5'-XMP aminase mutant as a parent gene to obtain 5 ' -XMP aminase having much higher activity, and determining nucleotide sequences of the resulting mutants. The 5'-XMP aminase mutants effectively convert 5 ' -XMP to 5 ' -guanylic acid because they have higher activity than the native form.
Abstract:
Disclosed herein are ammonia-specific 5'-XMP aminase mutants and a method for preparing the same. A mutation is introduced into the active site of glutamine-dependent catalysis in 5'-XMP aminase. The resulting 5'-XMP aminase mutant is devoid of the glutamine-dependent activity and specifically reacts with external ammonia in converting 5'- XMP into 5'-GMP. Thus, the ammonia-specific 5'-XMP aminase mutant is stabler within cells compared to the wild type, and can be useful in the industrial conversion of 5'-XMP into 5'-GMP.
Abstract:
Disclosed is a mutant strain of Corynebacterium ammoniagenes CJXFT0301 (KCCM-10530) , Corynebacterium aimoniagenes CJXSul0401 (KCCM-10609) , which produces 5'- xanthylic acid in high concentrations and high yields by direct fermentation. Also disclosed is a method of producing 5 ' -xanthylic acid, which is based on directly accumulating 5 '-xanthylic acid in culture fluid in high concentrations and high yields using the mutant strain. The present microorganism shares the characteristics of the CJXFT0301 (KCCM-10530) strain, requirement for adenine and guanine, susceptibility to lysozymes and resistance to praline analogues, glutamine analogues and tryptophan analogues. Due to its sulfadiazine resistance, leading to increased synthesis of dihydropteroate and eventually elevated levels of tetrahydrofolic acid, the present microorganism directly accumulates 5 ' -xanthylic acid in culture fluid in high concentrations and high yields during the same fermentation duration.
Abstract:
The invention relates to a microorganism, obtained by treating Corynebacterium ammoniagenes KCCM 10488 producing 5’- Xanthylic acid as parent strain with UV radiation and mutation Derivatives such as N-methyl-N’nitro-N-nitrosoguanidine (NTG), Having a resistance to 5-fluorotryptophan which enhances Biosynthesis of N5-N10- tetrahydrofolate used for transferring Two formyl group during the process of puring biosysthesis, making It possible to accumulate 5’xanthylic acid in culture medium at a high Yield and high concentration rate same period of fermentation.
Abstract:
The invention relates to Corynebacterium ammoniagenes CJXOL 0201 KCCM 10447 producing 5'-xanthylic acid. More specifically, the invention relates to Corynebacterium ammoniagenes CJXOL 0201 KCCM 10447 which is a mutant strain of Corynebacterium ammoniagenes KCCM 10340 having a resistance to oligomycin. In order to obtain mutant strain having enhanced respiratory activity, the present invention adopted Corynebacterium ammoniagenes KCCM 10340 as parent strain and treated it with UV radiation and mutation derivatives such as N-methyl-N'-nitro-n-nitrosoguanidine(NTG) according to ordinary procedure. Therefore, Corynebacterium ammoniagenes CJXOL 0201 KCCM 10447 of the present invention makes it possible to increase ATP reproducing activity for same period of fermentation and can accumulate 5'xanthylic acid in culture medium at a high yield and concentration rate.
Abstract:
Disclosed herein are mutant strains, KCCM- 10784P and KCCM- 10785P, which are obtained through gene manipulation of Corynebacterium glutamicum KFCC-11074, and a process of producing L-glutamic acid using the mutant strains. The mutant strains are capable of producing L-Glutamic acid at high yield.
Abstract:
Provided are mutant strains derived from Escherichia sp. GPU1114 (Accession No. KCCM-10536), having cumulative inactivation of deoD, aphA , appA , and hprt genes, and methods of using the same.
Abstract:
The invention relates to Corynebacterium ammoniagenes CJXSP 0201 KCCM 10448 producing 5'-xanthylic acid. More specifically, the invention relates to Corynebacterium ammoniagenes CJXSP 0201 KCCM 10448 which is a mutant strain of Corynebacterium ammoniagenes KCCM 10340 having a resistance to osmotic pressure. In order to obtain mutant strain having enhanced respiratory activity, the present invention adopted Corynebacterium ammoniagenes KCCM 10340 as parent strain and treated it with UV radiation and mutation derivatives such as N-methyl-N'-nitro-n-nitrosoguanidine(NTG) according to ordinary procedure. Therefore, Corynebacterium ammoniagenes CJXSP 0201 KCCM 10448 of the present invention makes it possible to overcome growth-standing phase rapidly on early culture and for same period of fermentation, can accumulate 5'-xanthylic acid in culture medium at a high yield and concentration rate.